Market Expansion Opportunities Given uniQure's focus on gene therapy for severe genetic diseases and its innovative technology platform, there is substantial potential to collaborate with healthcare providers and research institutions seeking advanced gene therapy solutions to enhance their treatment options.

Strategic Partnerships The company's pipeline includes proprietary and partnered therapies, indicating opportunities to offer complementary technologies, data analytics, or manufacturing services that can accelerate clinical development and regulatory approval processes.

Regulatory Support Services With recent FDA approval delays and legal challenges, uniQure may benefit from regulatory consulting, compliance solutions, and risk management services to streamline approval pathways and manage investor relations effectively.

Financial and Legal Collaboration The ongoing securities class action lawsuits highlight a need for investor relations and corporate governance consulting, presenting opportunities to provide legal, financial communication, or crisis management solutions tailored to biotech firms.

Technology Integration Utilizing uniQure’s diverse tech stack, including Azure DevOps and Benchling, there is potential to offer software enhancements, data management tools, or cloud solutions that optimize their R&D workflows and improve project efficiency.